• Subcutaneous Daratumumab Effective Alternative to IV Formulation for Multiple Myeloma

    25 days ago - By Medscape

    Subcutaneous daratumumab could offer an effective and more convenient alternative to the IV formulation for patients with relapsed or refractory multiple myeloma, according to trial results.
    Reuters Health Information
    Read more ...